VTR · NYSE · REIT - Healthcare Facilities

Ventas (VTR)

Owns senior housing, outpatient medical buildings, research centers, and triple-net healthcare properties.

$87.03
vs last close−0.00 (−0.01%)
Loading prices…

Ventas, Inc.VTR
Real Estate

Owns senior housing communities, outpatient medical buildings, research centers, hospitals, and other healthcare real estate across North America and the U.K. Resident fees drive the operating portfolio, while medical, research, and triple-net assets produce rent through leases shaped by operator performance, tenant credit, healthcare regulation, and REIT rules.

Owns senior housing communities, outpatient medical buildings, research centers, hospitals, and other healthcare facilities across the United States, Canada, and the United Kingdom.

Collects resident fees and bears property costs in the Senior Housing Operating Portfolio (SHOP), where third-party managers run communities. The Outpatient Medical and Research portfolio (OM&R) and Triple-Net Leased Properties (NNN) produce rent; triple-net tenants generally cover property expenses. Operating data and operator relationships guide acquisitions, manager selection, and property performance. Recent investment has concentrated on senior housing.

Results depend on manager execution, tenant credit, hospital and university affiliations, and access to capital. Healthcare licensing, reimbursement, property regulation, and REIT distribution and asset tests constrain operations and financing.

Company facts

CEODebra A. Cafaro
ListedMay 5, 1997
ExchangeNYSE
HeadquartersChicago, IL
CountryUnited States
Employees542
CIK0000740260
ISINUS92276F1003

Market cap$42.31B
EPS (ttm)$0.5400
P/E (ttm)161.17
ROE2.0%
P/B2.89
P/S6.57
Dividend yieldDiv yield2.30%
Beta−0.20vs XLRE 0.97

Price target$101.00+16.1%Average of 32 analysts
ConsensusBuy18 of 32 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 21, 2026Evercore ISITarget
Target: $95
Target: $100
Sep 15, 2026JefferiesTarget
Target: $100
Target: $102
Sep 1, 2026Wells FargoReiterate
Rating: Target: $88
Rating: OverweightTarget: $104
Aug 31, 2026BarclaysReiterate
Rating: Target: $99
Rating: MixedTarget: $102
Aug 11, 2026BMO CapitalReiterate
Rating: Target: $100
Rating: OutperformTarget: $107

Next report
Oct 28, 26
in 36 days
EPS estimate
$0.16
Revenue estimate
$1.77B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$0.13$0.11$0.15$0.14$0.15$0.11$0.14Pending
Estimate$0.06$0.82$0.85$0.09$0.10$0.12$0.14$0.16
Surprise+105.3%−86.6%−82.4%+52.2%+49.0%−10.5%−1.6%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$1.29B$1.36B$1.42B$1.49B$1.57B$1.66B$1.73BPending
Estimate$1.26B$1.32B$1.38B$1.44B$1.50B$1.59B$1.68B$1.77B
Surprise+2.4%+3.2%+3.1%+3.6%+4.1%+4.5%+2.9%
Estimate$0.16
ReportedDue Oct 28, 2026
Estimate$1.77B
ReportedDue Oct 28, 2026
View details

Debt to equity93.20%
Current ratio27.20%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$1.24B$1.29B$1.36B$1.42B$1.49B$1.57B$1.66B$1.73B
Net income$19.2M$56.8M$46.9M$68.3M$66.0M$70.2M$55.9M$74.1M
Net margin1.6%4.4%3.5%4.8%4.4%4.5%3.4%4.3%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$182.1M$195.8M$197.7M$203.4M$221.5M$204.2M$191.6M$216.0M
YoY growth+106.2%+736.6%+22.2%+43.6%+21.7%+4.3%−3.1%+6.2%

Balance sheet, Jun 30, 2026Cash & short-term investments $199.0M · Total debt $13.65B · Total assets $29.66B · Shareholders' equity $14.65B

Revenue
$1.73B
Operating income
$216.0M
Net income
$74.1M
View details

Dividend yield
2.30%
Next ex-date
Sep 30, 26
in 8 days
Annual dividend
$2.00
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yieldUpcoming

Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Dividend$0.45$0.48$0.48$0.48$0.48$0.52$0.52$0.52
Annual yield3.06%2.66%2.95%2.70%2.48%2.40%2.25%2.34%
Ex-dateDec 31Mar 31Jun 30Sep 30Dec 31Mar 31Jun 30Sep 30
Payment dateJan 16Apr 17Jul 17Oct 16Jan 15Apr 16Jul 16Oct 15
View details

Institutions≈ 102.97%528.21M shares
976 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders0.19%993.5K shares
17 holders · as of Aug 4, 2026
Adds to103.16%

512.95M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 103.16%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
10.87%55.78Mas of Jun 30, 2026
JPMorgan Chase & CoInstitution
8.52%43.69Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
8.31%42.63Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
6.19%31.76Mas of Jun 30, 2026
State Street CorpInstitution
5.95%30.53Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jun 3, 2026Michael J. Emblerdirector+2,500$78.81
May 14, 2026Walter C. Rakowichdirector−1,152$90.20
Feb 11, 2026Carey S. Robertsofficer: EVP and GC−35,532$85.00
Feb 6, 2026Debra A. Cafarodirector, officer: Chairman and CEO−10,322$82.23
Feb 2, 2026Debra A. Cafarodirector, officer: Chairman and CEO−10,322$77.66
View details

Compare

CompanyPriceChange
Ventas$87.03−0.01%$42.31B161.2120.46.6+21.7%
Welltower$230.93−0.79%$167.72B123.283.313.3+39.1%
Healthpeak Properties$20.68−0.22%$14.28B59.2104.44.8+10.5%
Alexandria Real Estate Equities$53.99+1.21%$9.30B3.1−12.8%
Healthcare Realty$18.26−0.08%$6.41B317.45.6−1.8%
Omega Healthcare Investors$46.33−1.08%$14.01B16.723.910.8+11.5%
Sabra Health Care REIT$19.79−0.40%$5.01B75.727.35.8+24.7%
National Health Investors$67.36−0.75%$3.29B19.619.87.6+1.6%
LTC Properties$42.28−1.40%$2.19B15.421.56.3−46.2%
Median39.427.36.1+6.0%